Cointime

Isabl Inc.

company

About

Isabl integrates the whole genome and transcriptome to inform cancer care.

Highlights

Total Funding Amount
$3M
Funding Rounds
2
Investors
5
Employee Profiles
3

Details

Last Funding Type
Seed
Last Funding Money Raised
$3M
Industries
Biotechnology,Health Diagnostics,Hospital,Medical
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Isabl specializes in the fields of whole-genome cancer diagnostics. The company is currently looking to partner with oncology centers nationwide to showcase the value of using whole-genome sequencing in clinical cancer care.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3M
Isabl Inc. has raised a total of $3M in funding over 2 rounds. Their latest funding was raised on May 18, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2022 Seed $3M 4 Two Sigma Ventures — Detail
Jun 1, 2020 Series Unknown — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
5
Isabl Inc. is funded by 5 investors. Two Sigma Ventures and Milad Alucozai are the most recent investors.
Investor Name Lead Investor Funding Round
Two Sigma Ventures Yes Seed
Milad Alucozai — Seed
Sand Hill Angels — Seed
Y Combinator — Seed
Bossanova Investimentos — Series Unknown

Employee Profiles

Number of Employee Profiles
3
Isabl Inc. has 3 current employee profiles, including Executive Andrew Kung
Andrew Kung
Executive
Juan Medina
Executive
Elli Papaemmanuil
Executive
Cointime
เนื้อหา
บริษัท